Skip to content

Clinical trials

Completed Hepatitis, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20051
20061
20072
20082
20093
20102
20114
20122
20138
20142
20152
20164
20182
20191
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Gilead Sciences5
Pfizer3
Casa Sollievo della Sofferenza IRCCS2
GlaxoSmithKline2
Novartis Pharmaceuticals2
AbbVie1
AbbVie (prior sponsor, Abbott)1
Bachir Taouli1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic46
Hepatitis C16
Hepatitis15
Liver Diseases14
Hepatitis C, Chronic13
Virus Diseases10
Hepatitis, Viral, Human9
Digestive System Diseases7
Fibrosis7
Hepatitis B, Chronic7

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.